Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
The growing incidence of obesity, hypertension, and diabetes, coupled with the aging of the population, is increasing the prevalence of renal diseases in our society. Chronic kidney disease (CKD) is characterized by persistent inflammation, fibrosis, and loss of renal function leading to end-stage r...
Saved in:
| Main Authors: | Jose Luis Morgado-Pascual, Vanessa Marchant, Raul Rodrigues-Diez, Nuria Dolade, Beatriz Suarez-Alvarez, Bredford Kerr, Jose M. Valdivielso, Marta Ruiz-Ortega, Sandra Rayego-Mateos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/2931049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
by: Sandra Rayego-Mateos, et al.
Published: (2018-01-01) -
Epigenetic modifications in cardiac fibrosis: recent evidence of new pharmacological targets
by: Marian Pérez, et al.
Published: (2025-05-01) -
Emerging Epigenetic Therapies for the Treatment of Cardiac Fibrosis
by: Nerea Garitano, et al.
Published: (2025-05-01) -
Epigenetic modification in radiotherapy and immunotherapy for cancers
by: Shih-Kai Hung, et al.
Published: (2024-09-01) -
Intracellular HIV-1 Tat regulator induces epigenetic changes in the DNA methylation landscape
by: Andrea Rodríguez-Agustín, et al.
Published: (2025-03-01)